LILIANA BUSTAMANTE, MD
Medical Oncology Physician · CAPE CORAL, FL
Individual Active NPI 1881987303
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,468 | 338,998 | $23,303,785 | $8,850,980 | $7,044,965 |
| 2023 | 1,223 | 298,129 | $21,406,443 | $7,618,488 | $6,061,320 |
| 2022 | 1,225 | 324,403 | $18,132,096 | $6,361,656 | $5,098,134 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 27,200 | $56 | $45 |
| J1756 | Injection, iron sucrose, 1 mg | 24,000 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 23,800 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 15,470 | $2 | $1 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 13,260 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 12,960 | $49 | $39 |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg | 12,300 | $3 | $2 |
| J0897 | Injection, denosumab, 1 mg | 10,560 | $25 | $20 |
| J9299 | Injection, nivolumab, 1 mg | 8,500 | $31 | $25 |
| J9267 | Injection, paclitaxel, 1 mg | 8,233 | $0 | $0 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 7,900 | $8 | $6 |
| Q5129 | Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | 5,180 | $67 | $53 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | ME119232 | FL |
| Hematology (Internal Medicine) Physician | 207RH0000X | ME119232 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Florida
- NPI 1386850832
- NPI 1487858973
- NPI 1760590962
- NPI 1891775789
- NPI 1245551134
- NPI 1861843138
- NPI 1215101902
- NPI 1861729170
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.